These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1465811

  • 1. Fully parametric analysis of kidney graft survival.
    Vereerstraeten P.
    Transplant Proc; 1992 Dec; 24(6):2411-3. PubMed ID: 1465811
    [No Abstract] [Full Text] [Related]

  • 2. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E, Berthoux F, Acquart S, Lepetit JC.
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract] [Full Text] [Related]

  • 3. The graft survival curve: ideology and rhetoric.
    Guttmann RD.
    Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
    [No Abstract] [Full Text] [Related]

  • 4. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM, Sánchez J, Sánchez P, García J, Orero E, Beneyto I, Ros F.
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract] [Full Text] [Related]

  • 5. Cold ischemia time and MHC class II matching in renal transplants.
    Iwaki Y, Cicciarelli J, Aswad S, Gavazov M, Obispo E, Khetan U, Bogaard T, Asai P, Mendez RG, Mendez R.
    Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
    [No Abstract] [Full Text] [Related]

  • 6. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
    Martin S, Dyer PA, Scott PD.
    Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D, Ekberg H, Lindholm A, Persson H, Tufvesson G, Albrechtsen D.
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract] [Full Text] [Related]

  • 8. Influence of HLA matching on the outcome of kidney transplants in a single center analysis.
    Schanz D, Blümke M, Keller E, Tanzi-Fetta RF, Kirste G.
    Transplant Proc; 1992 Dec; 24(6):2455. PubMed ID: 1465828
    [No Abstract] [Full Text] [Related]

  • 9. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B, Ekberg H, Johnson U.
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract] [Full Text] [Related]

  • 10. HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
    Adam K, Polymenidis Z, Papakyriazi L, Alexopoulos E, Parapanissiou E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2449-50. PubMed ID: 1465825
    [No Abstract] [Full Text] [Related]

  • 11. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
    Cristol JP, Mourad G, Argiles A, Seignalet J, Iborra F, Ramounau-Pigot A, Chong G, Mion C.
    Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
    [No Abstract] [Full Text] [Related]

  • 12. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z, Adam K, Parapanissiou E, Sakellariou G, Papakyriazi E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract] [Full Text] [Related]

  • 13. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
    Velidedeoğlu E, Tokyay R, Haberal M.
    Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
    [No Abstract] [Full Text] [Related]

  • 14. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
    Gnant MF, Sautner T, Rosenmayr A, Muehlbacher F.
    Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
    [No Abstract] [Full Text] [Related]

  • 15. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E, Bittar AE, Losekann A, Deboni L, Ceretta F, Goldani JC, Garcia VD.
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract] [Full Text] [Related]

  • 16. Measures to improve early results in kidney transplantation.
    Schweizer RT, Roper L, Hull D, Bartus S.
    Transplant Proc; 1992 Dec; 24(6):2729-30. PubMed ID: 1465919
    [No Abstract] [Full Text] [Related]

  • 17. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
    Leivestad T, Berger L, Thorsby E.
    Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
    [No Abstract] [Full Text] [Related]

  • 18. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM, Sánchez P, Sánchez J, García J, Orero E, Beneyto I, Cruz JM.
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract] [Full Text] [Related]

  • 19. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
    Mjörnstedt L, Konar J, Skarp I, Olausson M, Sandberg L, Tufvesson G.
    Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
    [No Abstract] [Full Text] [Related]

  • 20. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J, Schreuder GM, Persijn GG, van Rood JJ.
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.